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Introduction 
Literature Review 
In 2005, Dr. Josep Dalmau described a con-
dition in four young women with ovarian tera-
tomas and precipitating antibodies generated 
against antigens highly expressed in the hip-
pocampus called N-methyl-d-aspartate 
(NMDA)  receptors (Dalmau et al., 2011). 
NMDA receptors are concentrated in the hip-
pocampus and play a vital role in synaptic 
adaptation processes that affect learning, 
memory, personality, movement and auto-
nomic regulation (Newcomer, Farber & 
Olney, 2000). Antibodies are formed in re-
sponse to antigens presented by a teratoma 
often found in the reproductive organs such 
as the ovaries or gonads and in some cases 
the antibodies formed are in response to neo-
plastic related antigens (Dalmau, 2016).  
These antibodies cross the blood brain barri-
er (BBB) and bind with NMDA receptors dis-
rupting their synaptic functionalities and caus-
ing neurobehavioural pathology (Ding, Jian, 
Stary, Yi and Xiaoaxing, 2015). The down 
regulation of NMDA receptor activity in the 
hippocampus results in changes in synaptic 
plasticity affecting learning and memory (Day, 
High, Cot, & Tang-Wai, 2011).  
Due to the pathology, patients may develop 
psychiatric symptoms, seizures, memory defi-
cits and abnormal movements (Ding, et al., 
2015). Focal neurological signs of the condi-
tion include decreased level of conscious-
ness, weakness in limbs, seizures, altered 
behavioural patterns, memory loss and confu-
sion (Dalmau et al., 2007). Patients present 
with psychiatric symptoms such as changes 
in personality, irritability or behavioural 
changes such as violence, agitation and par-
anoid thoughts. These symptoms are often 
misdiagnosed as their clinical presentation is 
consistent with psychosis and schizophrenia 
(Dalmau et al., 2007). The disruption of 
NMDA receptor activity also leads to disturb-
ances in respiratory drive that cause 
hypoventilation (requiring ventilatory support) 
and impedes the body’s autonomic functions 
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 that cause bradyarrhythmias (Dalmau et al., 
2016). Moreover, patients are then admitted 
to psychiatric facilities instead of acute care 
facilities, which prolongs timely diagnosis and 
intervention (Dalmau et al., 2007). Alterna-
tively, when patients are admitted to acute 
care facilities, the condition is often also mis-
taken for viral infections (Day et al., 2011).  
Studies have linked early intervention and 
treatment with complete recovery. However, 
delay in treatment could result in death 
caused by neuronal degeneration, respiratory 
and/or cardiac failure (Dalmau, 2016). The 
risk of relapse has been noted in 20 to 25 
percent of patients without teratomas, but this 
risk increases in patients if the teratomas 
have not been resected and treated appropri-
ately (Ding et al., 2015). This further makes 
the case for anti-NMDAR encephalitis to be 
considered as a differential diagnosis when 
patients present with autonomic dysregula-
tion, seizures and psychiatric features (Day 
et al., 2011). 
Objective 
The purpose of this case study is to raise 
awareness about this condition. It aims to 
encourage nurses, and other clinicians to 
consider it as a differential diagnosis in pa-
tients presenting with signs of fever, psychiat-
ric symptoms, seizures, memory deficits, ab-
normal movements and autonomic dysfunc-
tion.  
Epidemiology 
The first anti-NMDAR encephalitis case was 
reported in 2005, but it was only character-
ized as a condition by Dr. Josef Dalmau in 
2007 (Ding et al., 2015). The exact incidence 
of the condition is still not known (Kelly & 
Sexton, 2016). Anti-NMDAR encephalitis has 
been known as the most common cause of 
autoimmune encephalitis after acute demye-
linating encephalomyelitis (Dalmau, 2016). 
This condition has been noted in children and 
adults of all ages (Dalmau et al., 2011). Ap-
proximately 60 percent of diagnosed cases 
are associated with tumours, but there are 
many documented cases with no detectable 
tumour. It tends to occur in both males and 
females, however 80 percent of the diag-
nosed cases as yet have been women 
(Dalmau, 2016). The condition has recently 
gained more attention in popular media. Su-
sanah Cahalan, a journalist who worked for 
the New York Post shared a powerful narra-
tive of her personal experiences with the con-
dition in the book, ‘The Brain on Fire’. For a 
relatively rare condition, one academic hospi-
tal in an urban centre treated four cases in a 
single year. 
Clinical Presentation 
A notable clinical manifestation of anti-NMDA 
receptor encephalitis involves a triad of spe-
cific features that present as epilepsy, dyski-
nesia and psychiatric symptoms (Omura et 
al., 2015). A list of general clinical features 
such as focal neurological signs, psychiatric 
signs and autonomic instability noted in vari-
ous documented cases to date are listed in 
the Table 1.  
Diagnostics 
An analysis of serum and cerebrospinal fluid 
(CSF) via lumbar puncture (LP) is conducted 
to detect the presence of specific NMDA anti-
bodies (Dalmau, 2016). In addition, brain im-
aging via computer tomography (CT) is used 
to detect changes in the brain and  magnetic 
resonance imaging (MRI) is used to detect 
any underlying teratomas, particularly in the 
ovaries, gonads and mediastinal regions 
(Dalmau, 2016). Sometimes the tumours are 
undetectable and in these cases, a positron 
emission tomography (PET) scan may also 
be done (Kelly & Sexton, 2016).  Further-
more, an electroencephalogram (EEG) may 
reveal abnormal and/or focal slowing with 
epileptiform discharges (Kelly & Sexton, 
2016).  
Table 1. Clinical features noted in patients with Anti-NMDAR receptor encephalitis  
 
Focal neurological signs Weakness in limbs, seizures, altered behaviour, memory loss, 
confusion 
  
Psychiatric signs Auditory, visual and olfactory hallucinations; irritability, agitation, 
aggression and violent behaviour; catatonia 
  
Autonomic instability Fever, tachycardia/bradycardia, hypotension/hypertension, 
hypoventilation 
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Treatments 
In patients with primary tumours, the first 
course of treatment involves tumour resec-
tion (Halbert, 2016).  As these tumours have 
predominantly been noted in the ovaries of 
female patients, a laparascopic oophorecto-
my can be performed (Dalmau et al., 2007). 
Patients are treated with first-line immuno-
therapy treatment.  This includes corticoster-
oid therapy agents such as methylpredniso-
lone, dexamethasone and prednisolone to 
reduce inflammation in the brain. Concurrent 
treatment with H2 receptor antagonists such 
as ranitidine or pantoprazole are given to pre-
vent steroid induced mucosal damage 
(Omura et al., 2015). In addition, immuno-
therapies like intravenous immunoglobulin 
(IVIg) are administered to decrease inflam-
mation of the meninges and inhibit the bind-
ing of anti-NMDA antibodies. Also, plasma 
exchange may be used for treatment by 
Table 2. Clinical presentations, treatments and outcome of cases seen at our hospital 
Case Symptoms Treatment Adjunct therapies Complications Outcomes 
F, 25, 
A 
Aphasia, posturing 
(rigid), myoclonus 
jerks, tonic-clonic 
seizures, 
opsoclonus, 
decreased level of 
consciousness, 
respiratory 
difficulties, loss of 
tone, agitation, 
aggression 
Bilateral 
Oopherectomy 
ECT, 
Methylprednisolone, 
IVIG, Rituximab, 
Tetrabenzene, 
Quetiapine, 
Haloperidol, 
Olanzapine, 
Ketamine and 
Cyclophosphamide 
Intubation, 
ventilator 
associated 
pneumonia, 
bacteremia, status 
epilepticus, febrile 
neutropenia 
Complex care 
rehab, 
discharged 
home 
F, 22, 
B 
Confusion, 
hallucinations, global 
aphasia, agnosia, 
prosopagnosia, 
memory deficits, 
posturing, myoclonus 
and seizures 
Behavioural issues 
like cursing, spitting, 
yelling, agitation and 
aggression 
Bilateral 
Oopherectomy 
AEDs, Acyclovir, 
IVIG, 
plasmapheresis, 
methylprednisolone 
Manic symptoms, 
psychosis 
(Psychiatry 
consulted for 
unresolved mania) 
Repatriation, 
cognitive 
rehab, 
discharged 
home 
F, 30, 
C 
Brocca’s aphasia 
progressed to global 
aphasia, parasthesia 
in arms, generalized 
seizures, 
hallucinations, 
sensitivity to light and 
noise, agnosia, 
prosopagnosia, 
falling spells and 
wandering 
Right 
Oopherectomy 
RRR 
Methylprednisolone, 
IVIG 
UTI, allergic 
reaction to 
methylprednisolon
e (Psychiatry 
consulted for 
unresolved 
catatonia) 
Cognitive 
rehab, 
discharged 
home 
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removing anti-NMDA antibodies from the 
blood (Dalmau et al., 2007). Second-line im-
munotherapies such as rituximab or cyclo-
phosphamide, or both are used for patient 
showing little or no response to first-line im-
munotherapies (Dalmau, 2016).  
Case Studies 
Our first patient in 2016, whom we will 
refer to as Anna, was a 25-year-old, universi-
ty student who presented to a community 
hospital with agitation, aggression, myoclo-
nus jerks, generalized tonic clonic seizures, 
opsoclonus and tremors. Due to her psychiat-
ric symptoms, she was initially misdiagnosed 
and treated with antipsychotic medications. 
She also received six sessions of electrocon-
vulsive therapy. However, after noting a fe-
ver, rigidity and decreased level of con-
sciousness, a lumbar puncture was per-
formed. Anna tested positive for anti-NMDA 
receptor encephalitis. Although her MRI 
showed no signs of a teratoma, she was still 
treated with methylprednisolone and IVIg. 
After no improvements were noted, she was 
transferred to our Intensive Care Unit (ICU). 
She spent the next nine months in the ICU 
where she received plasma exchange and 
rituximab. She was further treated with tetra-
benzine, quetiapine, haloperidol, olanzapine 
and ketamine to suppress the myoclonus 
jerks, yet no improvement was noted. Upon a 
repeat MRI, a tiny right cystic teratoma was 
noted on her ovary. Due to the severity of her 
symptoms and to prevent relapse, Anna re-
ceived a bilateral oophorectomy and was 
subsequently treated for surgical meno-
pause.  
Anna went on to develop several com-
plications in the ICU including bacteremia, 
ventilator associated pneumonia, status epi-
lepticus and febrile neutropenia. Due to her 
slow recovery and following further consulta-
tion with Dr. Josef Dalmau, she was started 
on a monthly treatment of cyclophosphamide. 
After nine months, she was finally transferred 
to the inpatient unit where she presented with 
the symptoms outlined in Table 2. Her opso-
clonus myoclonus and seizures were uncon-
trollable and putting her at high risk for falls.  
We will refer to the next patient as Belle. She 
was a 22-year old female, who initially devel-
oped changes in her personality and started 
neglecting her personal hygiene following a 
vacation in Cuba. Belle was initially misdiag-
nosed with a psychiatric illness, started on 
anti-psychotic medications in a community 
hospital and discharged home. She was 
found unresponsive at home and re-admitted 
the following day. She also presented with 
posturing, rigidity and severe myclonus. Belle 
was treated with anti-epileptic drugs and Acy-
clovir for suspected viral encephalitis. Her 
MRI was normal, but her cerebrospinal fluid 
(CSF) tested positive for Anti-NMDA receptor 
antibodies at the community hospital. Upon 
confirmation of the diagnosis, she was trans-
ferred to the ICU at our centre. 
Belle’s symptoms were similar to 
Anna’s symptoms. They both had hallucina-
tions, agnosia and prosopaganosia as men-
tioned in Table 2. Furthermore, Belle present-
ed with severe psychosis. She was cursing, 
spitting, yelling, was often whispering, agitat-
ed and aggressive. Belle was treated with 
IVIG, plasmapheresis and steroid therapy, 
but continued to have seizures. She was 
treated with multiple anti-epileptic medica-
tions. Her MRI showed no evidence of a tera-
toma. Despite this, the physicians chose a 
bilateral oophorectomy as she was deterio-
rating quickly. Her symptoms improved dras-
tically after surgery. The pathology of her 
ovaries later revealed a microscopic terato-
ma. She was started on hormone therapy for 
surgically induced menopause and trans-
ferred to our inpatient unit. Despite improve-
ments in her symptoms, her manic symptoms 
had not yet improved. A plan was needed to 
address Belle’s manic symptoms, behaviour-
al issues, her safety and the safety of staff 
caring for her during the agitated periods.   
Our last patient (whom we will call Cathe-
rine), was a 30- year old female whose symp-
toms began with facial twitching and pares-
thesia in her right arm. She reported having 
some word finding difficulty for a week. Later 
in the week, she had a tonic-clonic seizure 
and fell down at a baseball game. Post-
seizure, Catherine was brought to our emer-
gency department for her progressive apha-
sia and a new onset of focal seizures. Her 
brain MRI and CT were unremarkable. An 
EEG showed diffused slowing, but no abnor-
malities. However, Catherine continued to 
present with global aphasia, visual hallucina-
tion, agnosia, falling spells and a sensitivity to 
light and noise (Table 2). Unlike Anna and 
Belle, she did not exhibit agitation nor ag-
gression.  
A pelvic MRI revealed a 5cm ovarian terato-
ma and an LP further confirmed the presence 
of anti-NMDAR antibodies in her CSF. She 
was started on IVIG treatments and her 
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teratoma was resected within eight days of 
her admission. She was also started on IV 
steroid therapy, but developed a reaction to 
it. As a result, the steroids were discontinued.  
Nursing Implications 
Acute Confusion Management 
Each of these patients presented with unique 
and unpredictable symptoms making their 
medical management incredibly complex. 
Matata et al. (2015) suggests it is important 
for nurses to ensure a thorough Mini-mental 
status exam and Glasgow Coma Scale 
(GCS) assessment is performed to establish 
a patient’s baseline on admission. Thereafter, 
a Confusion Assessment Method (CAM) and 
GCS must be performed regularly every shift 
in coordination with the physician’s order. 
These tests enable nurses to detect minute 
changes in the patient’s physiological and 
psychological status, and enhance communi-
cation to the team for psychiatric manage-
ment. Matata et al. (2015) suggest that pa-
tients with this condition often develop para-
noia. Thus, patients may benefit from nurses 
clustering their interventions to minimize 
stress and decrease stimulation (Matata et 
al., 2015). In addition, Matata et al. (2015) 
also suggest that the concerns of family or 
relatives at the bedside be taken seriously as 
they could be an indicator of the patient de-
veloping subtle psychiatric features. Nurses 
can play a crucial role in advocating for refer-
rals to psychology, neuropsychology and 
mental health services within the interdiscipli-
nary team. 
Seizure Management 
According to Dalmau et al., (2007), seizures 
are a characteristic symptom of the condition. 
Focal seizures, generalized seizures, status 
epilepticus and non-convulsive status epilep-
ticus have all been noted in patients with Anti
-NMDAR encephalitis (Dalmau, 2016). Nurs-
es should monitor the patients closely for
changes in behaviour and confusion as they
could be signs of seizures. It is also important
to prepare the bedside with safety equipment
such as airway management equipment and
intravenous (IV) access to allow for quick and
effective seizure management in order to pre-
vent brain injury.
Guven, Aydin & Kaykis (2017) define status 
epilepticus as a critical condition in which a 
seizure lasts for more than five minutes or 
when two or more seizures occur without any 
improvement. Brain injury can ensue as early 
as the five minutes into sustained seizure 
activity (Ramazan, et al., 2017). As a result, it 
is imperative to prepare for the administration 
of medications like IV lorazepam, phenytoin, 
midazolam and diazepam to manage status 
epilepticus effectively (Matata et al, 2015).  
Non-convulsive status epilepticus (NCSE) in 
patients with an altered mental status have 
also been noted in this population (Day et al., 
2011). Hassan (2016) describes NCSE as a 
prolonged seizure without perceptible motor 
signs but with an altered mental status and 
continuous epileptiform EEG changes. NCSE 
should be monitored closely for changes and 
communicate updates to the team as they 
may need continuous EEG monitoring and 
might need to be treated with anti-epileptic 
medications. 
Memory Loss 
Long term cognitive effects such as memory 
loss, disinhibition and impulsiveness, impair-
ments in executive function such as inatten-
tion, poor organization and planning difficul-
ties have been noted in this population 
(Bach, 2014). As a result, patients may re-
quire total assistance with activities of daily 
living (ADL). Occupational therapy and Physi-
otherapy may be required to help manage 
and to develop a plan care around the pa-
tient’s general physical deconditioning 
(Tham, 2012).  
All three of the previously discussed cases 
developed agnosia (inability to process sen-
sation and recognize objects), prosopagnosia 
(inability to recognize faces), receptive apha-
sia (inability to comprehend language) and 
expressive aphasia (inability to speak) in 
some capacity (Dalmau et al., 2007). In addi-
tion, the patients also exhibited dysphagia 
and communication deficits, requiring a 
Speech Language Pathologist (SLP) consult.  
Patient Safety, Staff Safety and Transition-
al Care 
All our patients’ families were quite involved 
in their care and tried to stay at the bedside 
as much as possible. However, when the 
families were unable to do so, a plan was 
developed for every single patient to ensure 
that their unique medical and psychosocial 
needs were being met, especially in regards 
to patient safety. The nurse to patient ratios 
on the inpatient unit is one to five versus one 
on one in the ICU. Their transitional needs 
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became more apparent during their transition 
from ICU to the inpatient unit. Families may 
have difficulty adjusting to the fact that the 
care provided on the inpatient unit is no long-
er on a one-on-one basis.  
Families will require additional emotional sup-
port. Organizing family meetings can be help-
ful in communicating ongoing updates and 
establishing the goals of care. Nurses play a 
crucial role in initiating the discharge planning 
process from the point of admission and ad-
vocating for patients to receive all the appro-
priate referrals and services prior to dis-
charge. Nursing representation at family 
meetings is also critical to help ensure fami-
lies understand the plan and goals of care.  
Due to the possibility of tonic-clonic seizures, 
posturing and myoclonus jerks, patients with 
anti-NMDAR are at high risk of falls. Strate-
gies such as bed alarms, placing falls mats 
on the floor, ensuring the patient’s belongings 
were within reach, establishing a toileting 
routine, providing non-slip slippers, placing 
the bed to the wall and de-cluttering the bed-
side space were quite useful in preventing 
falls in these patients.  
Some patients with this condition may be-
come quite violent and aggressive during the 
psychosis stage. It is recommended that a 
behavioural safety alert and plan be imple-
mented to ensure the safety of the patient, 
family members and all staff in the interdisci-
plinary team. All possible options must be 
explored before the use of physical restraints 
such as soft mitts, restraint jackets and wrist 
restraints. It is recommended that chemical 
and physical restraints be used with caution 
to prevent patients from harming themselves, 
their families and staff. In addition to medical 
and safety concerns, another downside to the 
use of restraints is the distress it may cause 
to both patients and their family members. 
Nurses should provide ongoing emotional 
support to distressed family members as a 
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part of the discussion about the goals of care 
for such patients. Other alternatives may be 
explored and agreed upon in discussion with 
family members at family meetings. For ex-
ample, constant observers or “sitters” were 
organized for patients whose family members 
were distressed by the use of restraints for 
our patients.  
Although medicine is more informed about 
the condition today than ever before, patients 
and families may struggle to cope with the 
rarity of the condition, the lack of information 
about the condition and the devastating ef-
fects of a oophorectomy or hysterectomy, 
early menopause and possible life altering 
changes. The families of all three patients 
were provided ongoing emotional support 
and offered spiritual care services or referred 
to hospital chaplains. They were also referred 
to support groups such as the Anti-NMDA 
Receptor Encephalitis Foundation and social 
services when appropriate.  
Patient Outcomes 
Anna was transferred to a Complex Care Re-
habilitation facility and moved back home 
with her family. Although, Anna did not return 
completely back to her baseline, she is 
healthy again and doing very well. Her family 
says that her cognition has improved, and 
that she is talking and walking again. Her 
family also mentioned she is attending day 
programs three times a week and spending a 
lot of time engaged in activities with family 
and friends.  
A Psychiatry consult was arranged for Belle 
and she was started on anti-psychotic medi-
cations to manage her agitation and violent 
behaviour. Upon successful medical and psy-
chological management, Belle was repatriat-
ed to a community hospital in her hometown 
for further monitoring.  She received cognitive 
rehab for two months and she is still receiv-
ing treatment on an outpatient basis.  She is 
currently working through a program offered 
by the March of Dimes of Canada. The com-
munity based rehabilitation program helps 
people with disabilities transition back into 
the work force. As per family, she has almost 
returned back to her baseline and hopes to 
attend college next year. 
Following her improvement, Catherine was 
discharged to a cognitive rehabilitation centre 
close to her family home. She has almost 
completely recovered, has returned to work 
at her previous position. She continues to be 
followed by   Neuropsychiatry at our hospital. 
Discussion 
Prior to 2005, undiagnosed and untreated 
patients with this condition often developed 
complications such as infections, cognitive 
and motor dysfunction, life long impairments 
and even death (Dalmau et al., 2007). In a 
multi-institutional observation study Titulaer 
et al. (2013) reported that out of 577 patients, 
495 became bedridden and 440 were admit-
ted to the ICU at some point, 394 went on to 
reach good outcomes and 30 patients ended 
up dying. The patients in this case study pre-
sented with both neurological and psychiatric 
features similar to those noted in literature. 
However, thanks to the advances made by 
Dr. Josef Dalmau, in comparison to cases 
prior to 2005, the patients in this case study 
faired relatively well with two going back to 
work and one returning home to live with her 
family. The value of early diagnosis and treat-
ment is colossal to the successful recovery of 
patients suffering from anti-NMDAR enceph-
alitis.  
In summary, the triad noted often in this pa-
tient population is seizures, psychosis and 
dyskinesia (Dalmau, 2016). Based on their 
observational study, Titulaer et al. (2013) 
suggest that early diagnosis and timely inter-
vention is predictive of improved outcomes in 
this patient population. Nurses, physicians 
and allied health professionals especially in 
community health, emergency and neurology 
departments, family medicine and psychiatric 
facilities play an integral role in recognizing 
symptoms earlier on and facilitating or deliv-
ering timely medical intervention to these pa-
tients. Nurses in particular play a crucial role 
in supporting patients and their families 
through this rare and distressing neurological 
condition. Nursing implications include regu-
larly communicating ongoing neurological 
developments to the team, acute confusion 
management, seizure management, respira-
tory and cardiac monitoring, making appropri-
ate referrals, patient advocacy, providing 
emotional support, coordinating additional 
support services, educating patients and fam-
ilies, ensuring patient and staff safety and 
discharge planning. 
Acknowledgements 
The patients and their families, 
Arlene Vasconcelos, Adassa Wilson, 
Aline Ha, Charmaine Arulvarathan, Nadia 
Walfall, George Crasto and Valerian Gladys 
Crasto 
Australasian Journal of Neuroscience  Volume 29 ● Number 1 ● May 2019 
 
References 
Bach, L. J., (2014). Long Term Rehabilitation 
Management and outcome of anti-NMDA 
receptor encephalitis: Case Reports. Neu-
rorehabilitation 35: 863-875.  
 Dalmau, J., (2016). NMDA receptor enceph-
alitis and other antibody-mediated disorders  
of the synapse-The 2016 Cotzias Lecture. 
American Academy of Neurology, 87:2471-
2482. 
Dalmau, J., Lancaster, E., Matinez-
Hernandez, E., Rosenfeld, M., Balice-
Gordon, R., (2011). Clinical Experience and 
Laboratory Investigations in patients with Anti
- NMDA receptor encephalitis. The Lancet – 
Neurology 10 (1): 63-74. 
Dalmau, J., Tuzun, E., Wu, H., Masjuan, J., 
Rossi, J. E., Voloschin, A., Lynch, D. R., 
(2007). Paraneoplastic Anti-N-methyl-D-
aspartate receptor encephalitis associated 
with  ovarian teratoma. Annals of Neurology, 
61:25-36. 
Day, G. S., High, S. M., Cot, B. & Tang-Wai, 
D., (2011). Anti-NMDA receptor Encephalitis: 
Case report and literature review of an under-
recognized condition. Journal of General In-
ternal Medicine, 26 (7): 811-816. 
Day, G. S., Laiq, S., Tang-Wai, D. F. & Mun-
hoz, D., (2014). Abnormal neurons in terato-
mas in NMDAR encephalitis. JAMA Neurolo-
gy, 71 (6):717-724.   
Ding, H., Jian, Z, Stary, C. M., Yi, W and 
Xiaoaxing, X., (2015). Molecualr Pathogene-
sis of Anti-NMDAR encephalitis. BioMed Re-
search International, 1: 1-6. 
Guven, R., Aydin, M. N. and Kaykisiz, E. K., 
(2017). An emergency medicine perspective 
for non-convulsive status epilepticus. Eura-
sian Journal of Emergency Medicine. 16: 83-
89. 
Halbert, R. K., (2016). Anti-N-methyl-D-
aspartate receptor encpehalitis. Journal of 
Neuroscience Nursing, 48(5): 270-273. 
Hasan, A., Q., (2016). Non Convulsive Status 
Epilepticus in Emergency Department: A di-
agnostic Challenge. Journal of Medical Sci-
ence and Clinical Research, 4(8): 12305-
12308. 
Kelly, L. J., & Sexton, V. L., (2016). Anti 
NMDA encephalitis. The Neurodiagnostic 
Journal, 56:101-108.  
Matata, C et al., (2015). Managing patients 
with encephalitis. Nursing Standard,30(11): 
50-58. 
Newcomer, J. W., Farber, N. B. & Olney, J. 
W., (2000). NMDA receptor function, 
memory, and brain aging. Dialogues in Clini-
cal Neurosciences, 2(3): 219–232. 
Omura, T., Sonoda, S., Nagata, K., Okita, T., 
Hoshiai, A., Sano, H., Shoichi, O., (2015). 
Acute Medicine & Surgery, 2: 56-59. 
Titulaer, M. J., McCracken, L., Gabilondo, I., 
Armangue, T., Glaser, C., Lizuka, T., … 
Dalmau, J., (2013). Treatment and prgnostic 
factors for long-term outcome in patients with 
anti-N-Methyl-D-Aspartate (NMDA) receptor 
encephalitis: a cohort study. The Lancet – 
Neurology 12 (2): 157-165. 
Tham SL, Kong KH (2012) A case of anti-
NMDAR (N-methyl-D- aspartate receptor) 
encephalitis: a rehabilitation perspective. 
NeuroRehabilitation. 30 (2) 109-112.  
